NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neodocs

Neodocs

Private
MumbaiHealthcare & Life Scienceshttps://neodocs.in/

Last Round

Seed

Feb 8, 2024

Total Funding Raised

$2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Neodocs is a health technology company that provides smartphone-based medical testing solutions for at-home diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Computer Vision, Healthcare Analytics

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

diagnostic test stripspoint-of-care testingat-home diagnosticssmartphone diagnosticscomputer visionhealth screeningbiomarker analysisdigital healthtelemedicinemedical deviceslab-on-a-chipremote patient monitoringRPMhealth techmHealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neodocs Comparables

Compare Neodocs with similar companies based on industry and business-model similarity.

Neodocs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vessel Health
81%
TestCard
80%
Vivoo
80%

Neodocs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 8, 2024
Pre SeedAug 25, 2021
Pre SeedDec 2, 2020

Key People

Founding team and executive leadership

Nikunj Malpani

Co-Founder CEO

Founding Team

Neodocs Investors

Notable investors and investment history

Neodocs investors
InvestorRounds
Omidyar Network IndiaSeed
Titan CapitalPre Seed, Seed
Titan CapitalSeed, Pre Seed
Y CombinatorSeed, Pre Seed
Prophetic VenturesPre Seed
100UnicornsSeed, Pre Seed
Gemba CapitalPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Active projects and partners named in Philippines, Indonesia, Sri Lanka, Cameroon, and Nepal.

  • Oct 1, 2025

    Company has conducted over 250,000 tests.

Neodocs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neodocs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neodocs's valuation, stock price, and market status.

Firmographic Details

HeadquartersMumbai
Employee Range46
Year Founded2020
Last FundingFeb 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.